Top compounds associated with response to AL513412.1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.8
mRNA myriocin CTRPv2 pan-cancer AAC -0.026 0.8
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.012 0.8
mRNA TGX221 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.014 0.8
mRNA procarbazine CTRPv2 pan-cancer AAC -0.012 0.8
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA QS11 CTRPv2 pan-cancer AAC 0.023 0.8
mRNA AC55649 CTRPv2 pan-cancer AAC -0.011 0.8
Download CSV